Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study.

Vilar-Gomez E, Athinarayanan SJ, Adams RN, Hallberg SJ, Bhanpuri NH, McKenzie AL, Campbell WW, McCarter JP, Phinney SD, Volek JS, Chalasani N.

BMJ Open. 2019 Feb 25;9(2):e023597. doi: 10.1136/bmjopen-2018-023597.

2.

Improvement in patient-reported sleep in type 2 diabetes and prediabetes participants receiving a continuous care intervention with nutritional ketosis.

Siegmann MJ, Athinarayanan SJ, Hallberg SJ, McKenzie AL, Bhanpuri NH, Campbell WW, McCarter JP, Phinney SD, Volek JS, Van Dort CJ.

Sleep Med. 2019 Mar;55:92-99. doi: 10.1016/j.sleep.2018.12.014. Epub 2019 Jan 3.

3.

Paradox of hypercholesterolaemia in highly trained, keto-adapted athletes.

Creighton BC, Hyde PN, Maresh CM, Kraemer WJ, Phinney SD, Volek JS.

BMJ Open Sport Exerc Med. 2018 Oct 4;4(1):e000429. doi: 10.1136/bmjsem-2018-000429. eCollection 2018.

4.

Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study.

Bhanpuri NH, Hallberg SJ, Williams PT, McKenzie AL, Ballard KD, Campbell WW, McCarter JP, Phinney SD, Volek JS.

Cardiovasc Diabetol. 2018 May 1;17(1):56. doi: 10.1186/s12933-018-0698-8.

5.

Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study.

Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, Hazbun TL, Volk BM, McCarter JP, Phinney SD, Volek JS.

Diabetes Ther. 2018 Apr;9(2):613-621. doi: 10.1007/s13300-018-0386-4.

6.

Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study.

Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, Hazbun TL, Volk BM, McCarter JP, Phinney SD, Volek JS.

Diabetes Ther. 2018 Apr;9(2):583-612. doi: 10.1007/s13300-018-0373-9. Epub 2018 Feb 7. Erratum in: Diabetes Ther. 2018 Mar 5;:.

7.

Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes.

Saslow LR, Daubenmier JJ, Moskowitz JT, Kim S, Murphy EJ, Phinney SD, Ploutz-Snyder R, Goldman V, Cox RM, Mason AE, Moran P, Hecht FM.

Nutr Diabetes. 2017 Dec 21;7(12):304. doi: 10.1038/s41387-017-0006-9.

8.

Comparison of good days and sick days of school-age children with cancer reflected through their drawings.

Linder LA, Bratton H, Nguyen A, Parker K, Phinney S.

Qual Life Res. 2017 Oct;26(10):2729-2738. doi: 10.1007/s11136-017-1621-6. Epub 2017 Jun 13.

9.

A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes.

McKenzie AL, Hallberg SJ, Creighton BC, Volk BM, Link TM, Abner MK, Glon RM, McCarter JP, Volek JS, Phinney SD.

JMIR Diabetes. 2017 Mar 7;2(1):e5. doi: 10.2196/diabetes.6981.

10.

Metabolic characteristics of keto-adapted ultra-endurance runners.

Volek JS, Freidenreich DJ, Saenz C, Kunces LJ, Creighton BC, Bartley JM, Davitt PM, Munoz CX, Anderson JM, Maresh CM, Lee EC, Schuenke MD, Aerni G, Kraemer WJ, Phinney SD.

Metabolism. 2016 Mar;65(3):100-10. doi: 10.1016/j.metabol.2015.10.028. Epub 2015 Nov 2.

11.

It is time to bust the myth of physical inactivity and obesity: you cannot outrun a bad diet.

Malhotra A, Noakes T, Phinney S.

Br J Sports Med. 2015 Aug;49(15):967-8. doi: 10.1136/bjsports-2015-094911. Epub 2015 Apr 22. No abstract available.

PMID:
25904145
12.

Effects of step-wise increases in dietary carbohydrate on circulating saturated Fatty acids and palmitoleic Acid in adults with metabolic syndrome.

Volk BM, Kunces LJ, Freidenreich DJ, Kupchak BR, Saenz C, Artistizabal JC, Fernandez ML, Bruno RS, Maresh CM, Kraemer WJ, Phinney SD, Volek JS.

PLoS One. 2014 Nov 21;9(11):e113605. doi: 10.1371/journal.pone.0113605. eCollection 2014.

13.

Rethinking fat as a fuel for endurance exercise.

Volek JS, Noakes T, Phinney SD.

Eur J Sport Sci. 2015;15(1):13-20. doi: 10.1080/17461391.2014.959564. Epub 2014 Oct 2. Review.

PMID:
25275931
14.

The impact of an ultramarathon on hormonal and biochemical parameters in men.

Kupchak BR, Kraemer WJ, Hoffman MD, Phinney SD, Volek JS.

Wilderness Environ Med. 2014 Sep;25(3):278-88. doi: 10.1016/j.wem.2014.03.013. Epub 2014 Jun 13.

PMID:
24931590
15.

Low-carbohydrate diets for athletes: what evidence?

Noakes T, Volek JS, Phinney SD.

Br J Sports Med. 2014 Jul;48(14):1077-8. doi: 10.1136/bjsports-2014-093824. Epub 2014 May 26. No abstract available.

PMID:
24861453
16.

A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes.

Saslow LR, Kim S, Daubenmier JJ, Moskowitz JT, Phinney SD, Goldman V, Murphy EJ, Cox RM, Moran P, Hecht FM.

PLoS One. 2014 Apr 9;9(4):e91027. doi: 10.1371/journal.pone.0091027. eCollection 2014.

17.

Alterations in coagulatory and fibrinolytic systems following an ultra-marathon.

Kupchak BR, Volk BM, Kunces LJ, Kraemer WJ, Hoffman MD, Phinney SD, Volek JS.

Eur J Appl Physiol. 2013 Nov;113(11):2705-12. doi: 10.1007/s00421-013-2709-5. Epub 2013 Aug 22.

PMID:
23974848
18.

Bayesian modeling of pretransplant variables accurately predicts kidney graft survival.

Brown TS, Elster EA, Stevens K, Graybill JC, Gillern S, Phinney S, Salifu MO, Jindal RM.

Am J Nephrol. 2012;36(6):561-9. doi: 10.1159/000345552. Epub 2012 Dec 5.

19.

The effect of platelet-rich plasma on normal soft tissues in the rabbit.

Harris NL, Huffer WE, von Stade E, Larson AI, Phinney S, Purnell ML.

J Bone Joint Surg Am. 2012 May 2;94(9):786-93. doi: 10.2106/JBJS.J.00984.

PMID:
22552667
20.

Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet.

Forsythe CE, Phinney SD, Feinman RD, Volk BM, Freidenreich D, Quann E, Ballard K, Puglisi MJ, Maresh CM, Kraemer WJ, Bibus DM, Fernandez ML, Volek JS.

Lipids. 2010 Oct;45(10):947-62. doi: 10.1007/s11745-010-3467-3. Epub 2010 Sep 7.

21.

Sixty-four slice multidetector computed tomographic angiography in the evaluation of vascular trauma.

White PW, Gillespie DL, Feurstein I, Aidinian G, Phinney S, Cox MW, Adams E, Fox CJ.

J Trauma. 2010 Jan;68(1):96-102. doi: 10.1097/TA.0b013e318190c4ca.

PMID:
19779310
22.

Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet.

Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, Kraemer WJ, Bibus DM, Fernandez ML, Feinman RD.

Lipids. 2009 Apr;44(4):297-309. doi: 10.1007/s11745-008-3274-2. Epub 2008 Dec 12.

PMID:
19082851
23.

Oolichan grease: a unique marine lipid and dietary staple of the north Pacific coast.

Phinney SD, Wortman JA, Bibus D.

Lipids. 2009 Jan;44(1):47-51. doi: 10.1007/s11745-008-3243-9. Epub 2008 Oct 14.

PMID:
18853216
24.

Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome.

Volek JS, Fernandez ML, Feinman RD, Phinney SD.

Prog Lipid Res. 2008 Sep;47(5):307-18. doi: 10.1016/j.plipres.2008.02.003. Epub 2008 Mar 15. Review.

PMID:
18396172
25.

Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation.

Forsythe CE, Phinney SD, Fernandez ML, Quann EE, Wood RJ, Bibus DM, Kraemer WJ, Feinman RD, Volek JS.

Lipids. 2008 Jan;43(1):65-77. Epub 2007 Nov 29.

PMID:
18046594
26.

Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.

Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G.

J Ren Nutr. 2007 Sep;17(5):296-304.

PMID:
17720098
27.

Low-carbohydrate nutrition and metabolism.

Westman EC, Feinman RD, Mavropoulos JC, Vernon MC, Volek JS, Wortman JA, Yancy WS, Phinney SD.

Am J Clin Nutr. 2007 Aug;86(2):276-84. Review.

PMID:
17684196
28.

Gamma-linolenate reduces weight regain in formerly obese humans.

Schirmer MA, Phinney SD.

J Nutr. 2007 Jun;137(6):1430-5.

PMID:
17513402
29.

The low fat paradox--do dietary carbohydrates increase circulating saturated fatty acids?

Phinney SD.

Am J Clin Nutr. 2006 Aug;84(2):461; author reply 461-2. doi: 10.1093/ajcn/84.1.461. No abstract available.

PMID:
16895898
30.

Antibody-drug conjugates designed to eradicate tumors with homogeneous and heterogeneous expression of the target antigen.

Kovtun YV, Audette CA, Ye Y, Xie H, Ruberti MF, Phinney SJ, Leece BA, Chittenden T, Blättler WA, Goldmacher VS.

Cancer Res. 2006 Mar 15;66(6):3214-21.

31.

Fatty acids, inflammation, and the metabolic syndrome.

Phinney SD.

Am J Clin Nutr. 2005 Dec;82(6):1151-2. No abstract available.

PMID:
16332644
32.

Comment: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets.

Kalvass JC, Phinney SD, Vernon MC, Rosedale R, Westman EC.

Ann Pharmacother. 2005 Jul-Aug;39(7-8):1371-2; author reply 1372. Epub 2005 May 31. No abstract available.

PMID:
15928257
33.

Ketogenic diets and physical performance.

Phinney SD.

Nutr Metab (Lond). 2004 Aug 17;1(1):2.

34.

A dietary supplement attenuates IL-6 and CRP after eccentric exercise in untrained males.

Phillips T, Childs AC, Dreon DM, Phinney S, Leeuwenburgh C.

Med Sci Sports Exerc. 2003 Dec;35(12):2032-7.

PMID:
14652498
35.

Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease.

Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G.

Kidney Int. 2003 Sep;64(3):978-91.

36.

Oral contraceptive use and increased plasma concentration of C-reactive protein.

Dreon DM, Slavin JL, Phinney SD.

Life Sci. 2003 Jul 25;73(10):1245-52.

PMID:
12850240
37.

Weight loss with self-help compared with a structured commercial program: a randomized trial.

Heshka S, Anderson JW, Atkinson RL, Greenway FL, Hill JO, Phinney SD, Kolotkin RL, Miller-Kovach K, Pi-Sunyer FX.

JAMA. 2003 Apr 9;289(14):1792-8.

PMID:
12684357
38.

The responses of serum and adipose Fatty acids to a one-year weight reduction regimen in female obese monozygotic twins.

Kunesová M, Phinney S, Hainer V, Tvrzická E, Stich V, Parízková J, Zák A, Stunkard A.

Ann N Y Acad Sci. 2002 Jun;967:311-23.

PMID:
12079858
39.

Assessment of dietary and genetic factors influencing serum and adipose fatty acid composition in obese female identical twins.

Kunesová M, Hainer V, Tvrzicka E, Phinney SD, Stich V, Parízková J, Zák A, Stunkard AJ.

Lipids. 2002 Jan;37(1):27-32.

PMID:
11876260
40.

Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.

Ahrén B, Magrum LJ, Havel PJ, Greene SF, Phinney SD, Johnson PR, Stern JS.

Obes Res. 2000 Sep;8(6):475-80.

41.

Self-help weight loss versus a structured commercial program after 26 weeks: a randomized controlled study.

Heshka S, Greenway F, Anderson JW, Atkinson RL, Hill JO, Phinney SD, Miller-Kovach K, Xavier Pi-Sunyer F.

Am J Med. 2000 Sep;109(4):282-7.

PMID:
10996578
42.

Essential fatty acids, membranes, and obesity.

Phinney SD.

Sb Lek. 1998;99(3):211-8. No abstract available.

PMID:
10358414
43.

Exercise training reduces skeletal muscle membrane arachidonate in the obese (fa/fa) Zucker rat.

Ayre KJ, Phinney SD, Tang AB, Stern JS.

J Appl Physiol (1985). 1998 Nov;85(5):1898-902.

44.

Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women.

Dubuc GR, Phinney SD, Stern JS, Havel PJ.

Metabolism. 1998 Apr;47(4):429-34.

PMID:
9550541
45.

Body composition of inactivated growth hormone (oMt1a-oGH) transgenic mice: generation of an obese phenotype.

Oberbauer AM, Stern JS, Johnson PR, Horwitz BA, German JB, Phinney SD, Beermann DH, Pomp D, Murray JD.

Growth Dev Aging. 1997 Fall-Winter;61(3-4):169-79.

PMID:
9546108
46.

The effect of dietary arachidonic acid on plasma lipoprotein distributions, apoproteins, blood lipid levels, and tissue fatty acid composition in humans.

Nelson GJ, Schmidt PC, Bartolini G, Kelley DS, Phinney SD, Kyle D, Silbermann S, Schaefer EJ.

Lipids. 1997 Apr;32(4):427-33.

PMID:
9113632
47.

A human dietary arachidonic acid supplementation study conducted in a metabolic research unit: rationale and design.

Nelson GJ, Kelley DS, Emken EA, Phinney SD, Kyle D, Ferretti A.

Lipids. 1997 Apr;32(4):415-20.

PMID:
9113630
48.

Gender differences in plasma leptin concentrations.

Havel PJ, Kasim-Karakas S, Dubuc GR, Mueller W, Phinney SD.

Nat Med. 1996 Sep;2(9):949-50. No abstract available.

PMID:
8782440
49.

Arachidonic acid maldistribution in obesity.

Phinney SD.

Lipids. 1996 Mar;31 Suppl:S271-4. Review.

PMID:
8729132
50.

Increased hepatic delta 6-desaturase activity with growth hormone expression in the MG101 transgenic mouse.

Nakamura MT, Phinney SD, Tang AB, Oberbauer AM, German JB, Murray JD.

Lipids. 1996 Feb;31(2):139-43.

PMID:
8835400

Supplemental Content

Loading ...
Support Center